Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Human Metabolome Technologies to Co-Develop Metabolomics Toolkit

NEW YORK, June 20 (GenomeWeb News) - Agilent Technologies and Japan's Human Metabolome Technologies will co-develop a suite of metabolomic analysis tools, the companies said today.


Under the agreement, the firms said they will integrate HMT's biochemical assays with Agilent's capillary electrophoresis and mass spectrometry technologies for analyzing metabolic markers.


Agilent and HMT said that the metabolomics solution is expected to be on the market within six months.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.